Neutrophils in oncolytic virus immunotherapy

Area of Science:

• Oncology
• Virology
• Immunology

Background:

• Oncolytic viruses are a promising cancer therapy, selectively targeting tumors and enhancing anti-tumor immunity.
• Intratumoral and intravenous administration are common, but face challenges like immune responses and non-specific uptake.
• Neutrophils, abundant leukocytes, have largely been overlooked in oncolytic virus therapy despite their antiviral roles.

Purpose of the Study:

• To review the current literature on the role of neutrophils in oncolytic virus therapy.
• To identify knowledge gaps regarding neutrophil function in this context.
• To provide a theoretical basis for enhancing oncolytic virus efficacy through neutrophil modulation.

Main Methods:

• Comprehensive literature search on neutrophils and oncolytic virus therapy.
• Analysis of existing studies on immune cell involvement in oncolytic virotherapy.
• Synthesis of findings to highlight the significance of neutrophils.

Main Results:

• Oncolytic viruses demonstrate potential in cancer treatment, with various administration routes.
• CD8+ T cells and NK cells are well-studied, but neutrophil involvement remains under-explored.
• Emerging evidence suggests neutrophils play a crucial role in antiviral responses.

Conclusions:

• Understanding neutrophil roles is critical for optimizing oncolytic virus therapy.
• Further research into neutrophils could lead to improved cancer treatment strategies.
• Targeting neutrophils may enhance the efficacy of oncolytic virus-based cancer therapies.